These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21263092)

  • 1. Treatment of low-risk gestational trophoblastic neoplasia.
    Aghajanian C
    J Clin Oncol; 2011 Mar; 29(7):786-8. PubMed ID: 21263092
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia.
    Gilani MM; Yarandi F; Eftekhar Z; Hanjani P
    Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):161-4. PubMed ID: 15760322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study.
    Covens A; Filiaci VL; Burger RA; Osborne R; Chen MD;
    Cancer; 2006 Sep; 107(6):1280-6. PubMed ID: 16900525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.
    AbrĂ£o RA; de Andrade JM; Tiezzi DG; Marana HR; Candido dos Reis FJ; Clagnan WS
    Gynecol Oncol; 2008 Jan; 108(1):149-53. PubMed ID: 17931696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole.
    Lurain JR
    Am J Obstet Gynecol; 2010 Dec; 203(6):531-9. PubMed ID: 20728069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour].
    Xiang Y; Wan XR; Sun ZJ; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):79-82. PubMed ID: 15840283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia.
    Chen LM; Lengyel ER; Bethan Powell C
    Gynecol Oncol; 2004 Jul; 94(1):204-7. PubMed ID: 15262143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.
    Osborne RJ; Filiaci V; Schink JC; Mannel RS; Alvarez Secord A; Kelley JL; Provencher D; Scott Miller D; Covens AL; Lage JM
    J Clin Oncol; 2011 Mar; 29(7):825-31. PubMed ID: 21263100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of metastatic gestational choriocarcinoma with oral methotrexate in a combat environment.
    Farley JH; Heathcock RB; Branch W; Larsen W; Homas D
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1250-4. PubMed ID: 15863599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
    Soper JT; Spillman M; Sampson JH; Kirkpatrick JP; Wolf JK; Clarke-Pearson DL
    Gynecol Oncol; 2007 Mar; 104(3):691-4. PubMed ID: 17137617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR; Nejad B
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor.
    Xiang Y; Sun Z; Wan X; Yang X
    J Reprod Med; 2004 Jun; 49(6):443-6. PubMed ID: 15283051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of drug resistant gestational trophoblastic neoplasia.
    Patel SM; Desai A
    J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
    Mahajan NN; Soni RN; Mahajan KN
    Am J Obstet Gynecol; 2007 Sep; 197(3):325; author reply 325. PubMed ID: 17826442
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of surgery in the management of high-risk gestational trophoblastic neoplasia.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):773-6. PubMed ID: 17086805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2010 Jun; 117(3):477-80. PubMed ID: 20347479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
    Chan KK; Huang Y; Tam KF; Tse KY; Ngan HY
    Am J Obstet Gynecol; 2006 Nov; 195(5):1282-6. PubMed ID: 16723109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational trophoblastic neoplasia management: an update.
    Ngan S; Seckl MJ
    Curr Opin Oncol; 2007 Sep; 19(5):486-91. PubMed ID: 17762576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia.
    Lurain JR
    Am J Obstet Gynecol; 2011 Jan; 204(1):11-8. PubMed ID: 20739008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.